189
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Patterns and Prevalence of BRCA1 and BRCA2 Germline Mutations Among Patients with Triple-Negative Breast Cancer: Regional Perspectives

ORCID Icon, ORCID Icon, , , ORCID Icon, & show all
Pages 4597-4604 | Published online: 09 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hikmat Abdel-Razeq, Lama Abujamous, Khansa Al-Azzam, Hala Abu-Fares, Hira Bani Hani, Mais Alkyam, Baha’ Sharaf, Shatha Elemian, Faris Tamimi, Fawzi Abuhijla, Sarah Edaily, Osama Salama, Hazem Abdulelah, Rand Daoud, Mohammad Abubaker & Areej Al-Atary. (2023) Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer. Breast Cancer: Targets and Therapy 15, pages 1-10.
Read now

Articles from other publishers (3)

Olfat Ahmad, Christian Sutter, Steffen Hirsch, Stefan M. Pfister & Christian P. Schaaf. (2023) BRCA1/2 potential founder variants in the Jordanian population: an opportunity for a customized screening panel. Hereditary Cancer in Clinical Practice 21:1.
Crossref
Shiva Sabzandam, Masoumeh Zahmatkeshan, Moein Adel, Mehrad Mehrdadian, Farzaneh Saliminia & Fariba Esmaeili. (2023) Investigating the therapeutic effect of folic acid conjugated ZnO nanoparticles on human triple negative breast cancer cell line. Zastita materijala 64:2, pages 213-222.
Crossref
Beata Smolarz, Anna Zadrożna Nowak & Hanna Romanowicz. (2022) Breast Cancer—Epidemiology, Classification, Pathogenesis and Treatment (Review of Literature). Cancers 14:10, pages 2569.
Crossref